More funds approved for COVAX vaccines, tighter access planned - statement

GENEVA: The board of the GAVI vaccine alliance has approved a further $775 million to fund the delivery of COVID-19 vaccines to lower-income economies over the next two years, as it plans to accelerate the rollout, it said on Friday.

The total funds available to cover the cost of delivering the vaccines will rise to $925 million, GAVI said in a statement issued after a two-day board meeting. COVAX, run jointly with the World Health Organization, has delivered 90 million doses to 132 countries since February, but has faced major supply issues since India suspended vaccine exports.